Pharmaceutical Technology on MSN
FDA approves Asahi Kasei’s Hovilpri for refractory HSV
The regulatory decision followed findings from PRIOH-1 Part C, an open-label, comparator-controlled Phase III superiority ...
FDA approves Hovilpri (pritelivir) for herpes lesions resistant to acyclovir, valacyclovir, or famciclovir in ...
WHEN doctors explained to Gaynor Jones why her face had suddenly changed overnight, she burst into tears with shock. A year ...
Johnson & Johnson (NYSE: JNJ) today announced new three-year data from the Phase 3 GALAXI 2 and 3 studies showing durable ...
Johnson & Johnson (NYSE: JNJ) today announced new Phase 3 data showing consistent combined fistula remission outcomes with ...
Trial met both co-primary endpoints of mean change from baseline in BCVA letter score and mean change from baseline in CST with statistical ...
Roughly half a year after the close of its deal to acquire Bayer spinout AiCurus, Asahi Kasei’s $920 million bet has paid off ...
A unified benchmarking framework comparing seven metaheuristics across six engineering plants and classical baselines finds ...
The US Food and Drug Administration (FDA) approved Hovilpri (pritelivir) tablets for adults with weakened immune systems (i.e ...
Asahi Kasei's $920 million takeover of German biotech Aicuris in April has paid off with FDA approval for the herpes simplex ...
Derry Journal on MSN
World renowned Derry biomedical scientist to receive Alumnus Illustrissimus Award
Distinguished Derry biomedical scientist and an internationally recognised leader in the fields of virology, infectious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results